Physician profile
Thomas S Beck
NPI 1275534679
$335.33
in general payments reported to CMS, 2019-2025
12 companies · $33.09 in 2025
The $33.09 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.61 · 2021: $67.17 · 2022: $57.40 · 2023: $93.33 · 2024: $46.73 · 2025: $33.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $65.52 | 2021-2022 | |
| Smith+Nephew, INC. | $49.66 | 2019-2021 | |
| Avanos Medical | $36.33 | 2022-2023 | On-Q* Pump and Accessories |
| Anika Therapeutics, INC. | $34.79 | 2023 | Ovomotion |
| Organogenesis INC. | $32.99 | 2024-2025 | Cygnus Dual, Puraply Am |
| Axonics, INC. | $22.26 | 2023 | Axonics |
| Amag Pharmaceuticals, INC. | $17.66 | 2019 | |
| Orthofix Medical, INC. | $17.36 | 2023 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $16.53 | 2024 | Exparel |
| Solventum Corporation | $15.36 | 2025 | Prevena, V.A.C. Veraflo |
| Medtronic, INC. | $14.94 | 2024 | Venaseal |
| Bioventus LLC | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Beck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.